Full View

Telmisartan, ramipril, or both in patients at high risk for vascular events

Ontarget Investigators - New England Journal of Medicine, 2008 - Mass Medical Soc
Background In patients who have vascular disease or high-risk diabetes without heart
failure, angiotensin-converting–enzyme (ACE) inhibitors reduce mortality and morbidity from …
被引用次数：4911 相关文章

[引用][C] Telmisartan, ramipril, or both in patients at high risk for vascular events

S Yusuf, K Teo, J Pogue, L Dyal, I Copland… - NEW ENGLAND …, 2008 - research.unipg.it
Telmisartan, ramipril, or both in patients at high risk for vascular events IRIS IRIS Home Sfoglia
Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN …

Telmisartan, ramipril, or both in patients at high risk for vascular events

S Yusuf, J Pogue, KK Teo, L Dyal, I Copland… - New England Journal …, 2008 - zora.uzh.ch
BACKGROUND: In patients who have vascular disease or high-risk diabetes without heart
failure, angiotensin-converting-enzyme (ACE) inhibitors reduce mortality and morbidity from …

Telmisartan, ramipril, or both in patients at high risk for vascular events

S Yusuf, KK Teo, J Pogue, L Dyal, I Copland… - 2008 - pubmed.ncbi.nlm.nih.gov
Background In patients who have vascular disease or high-risk diabetes without heart
failure, angiotensin-converting-enzyme (ACE) inhibitors reduce mortality and morbidity from …

Telmisartan, ramipril, or both in patients at high risk for vascular events

ONTARGET Investigators - New England …, 2008 - utsouthwestern.elsevierpure.com
Background: In patients who have vascular disease or high-risk diabetes without heart
failure, angiotensin-converting-enzyme (ACE) inhibitors reduce mortality and morbidity from …

Telmisartan, ramipril, or both in patients at high risk for vascular events.

S Yusuf, KK Teo, J Pogue, L Dyal… - The New England …, 2008 - europepmc.org
Background In patients who have vascular disease or high-risk diabetes without heart
failure, angiotensin-converting-enzyme (ACE) inhibitors reduce mortality and morbidity from …

[引用][C] Telmisartan, ramipril, or both in patients at high risk for vascular events.

S Yusuf, KK Teo, J Pogue, L Dyal… - New England Journal …, 2008 - dial.uclouvain.be
Telmisartan was equivalent to ramipril in patients with vascular disease or high-risk diabetes
and was associated with less angioedema. The combination of the two drugs was …

Telmisartan, ramipril, or both in patients at high risk for vascular events

G Lembo, M Volpe, S Yusuf, K Teo, J Pogue… - NEW ENGLAND …, 2008 - iris.uniroma1.it
BACKGROUND: In patients who have vascular disease or high-risk diabetes without heart
failure, angiotensin-converting-enzyme (ACE) inhibitors reduce mortality and morbidity from …

Telmisartan, ramipril, or both in patients at high risk for vascular events

S Yusuf, KK Teo, J Pogue, L Dyal… - New England …, 2008 - produccioncientifica.ucm.es
Telmisartan, ramipril, or both in patients at high risk for vascular events | Documentos -
Universidad Complutense de Madrid Logo Logo Identifícate Grupos Investigadores/as …
[PDF] archive.org

[PDF][PDF] Telmisartan, ramipril, or both in patients at high risk for vascular events

S Yusuf, J Pogue, KK Teo, L Dyal, I Copland… - N Engl J …, 2008 - scholar.archive.org
BACKGROUND: In patients who have vascular disease or high-risk diabetes without heart
failure, angiotensin-converting-enzyme (ACE) inhibitors reduce mortality and morbidity from …